logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Depala, Nishali
    Lawyer born in July 1987
    Individual (5 offsprings)
    Officer
    icon of calendar 2016-05-23 ~ now
    OF - Director → CIF 0
    Depala, Nishali
    Individual (5 offsprings)
    Officer
    icon of calendar 2016-05-23 ~ now
    OF - Secretary → CIF 0
    Mrs Nishali Depala
    Born in July 1987
    Individual (5 offsprings)
    Person with significant control
    icon of calendar 2016-06-20 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 2
    Mehta, Tanisha
    Consultant born in October 1989
    Individual (5 offsprings)
    Officer
    icon of calendar 2016-05-23 ~ now
    OF - Director → CIF 0
parent relation
Company in focus

SUERTE PHARMA LIMITED

Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Intangible Assets
23,742 GBP2024-10-31
28,922 GBP2023-10-31
Property, Plant & Equipment
9,984 GBP2024-10-31
13,312 GBP2023-10-31
Fixed Assets
33,726 GBP2024-10-31
42,234 GBP2023-10-31
Debtors
473,892 GBP2024-10-31
187,813 GBP2023-10-31
Cash at bank and in hand
584,358 GBP2024-10-31
0 GBP2023-10-31
Current Assets
1,110,701 GBP2024-10-31
237,813 GBP2023-10-31
Creditors
Current, Amounts falling due within one year
-774,959 GBP2023-10-31
Net Current Assets/Liabilities
-1,204,470 GBP2024-10-31
-537,146 GBP2023-10-31
Total Assets Less Current Liabilities
-1,170,744 GBP2024-10-31
-494,912 GBP2023-10-31
Net Assets/Liabilities
-1,172,641 GBP2024-10-31
-497,441 GBP2023-10-31
Equity
Called up share capital
100 GBP2024-10-31
100 GBP2023-10-31
Retained earnings (accumulated losses)
-1,172,741 GBP2024-10-31
-497,541 GBP2023-10-31
Equity
-1,172,641 GBP2024-10-31
-497,441 GBP2023-10-31
Average Number of Employees
602023-11-01 ~ 2024-10-31
672022-11-01 ~ 2023-10-31
Intangible Assets - Gross Cost
51,800 GBP2023-10-31
Intangible Assets - Accumulated Amortisation & Impairment
28,058 GBP2024-10-31
22,878 GBP2023-10-31
Intangible Assets - Increase From Amortisation Charge for Year
5,180 GBP2023-11-01 ~ 2024-10-31
Property, Plant & Equipment - Gross Cost
17,750 GBP2023-10-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
7,766 GBP2024-10-31
4,438 GBP2023-10-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
3,328 GBP2023-11-01 ~ 2024-10-31

  • SUERTE PHARMA LIMITED
    Info
    Registered number 10193832
    icon of address5 Northolt Trading Estate, Belvue Road, Northolt, Middlesex UB5 5QS
    Private Limited Company incorporated on 2016-05-23 (9 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2025-05-22
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 26 August 2025 and licensed under the Open Government Licence v3.0.